Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The report provides analysis of global Cardiovascular & Soft Tissue Repair Patches market for the period 2016-2026, wherein 2019 to 2026 is the forecast period and 2017 is considered as the base year. According to Acumen Research and Consulting, the global Cardiovascular & Soft Tissue Repair Patches market is expected to grow at noteworthy CAGR around 8 % throughout the forecast period and reach around US$ 6 billion by 2026, The growing application and prevalence of heart defects such as atrial septal and ventricular septal defects in medical procedures and sports wounds are a factor driving demand. Some of these factors drive demand.

Market Dynamics

Heart conditions have been closely followed by heart stroke, which is the leading cause of death in the US. An estimated 85.6 million in the U.S. live with high blood pressure, heart attack, stroke, and cardiovascular diseases. These statistics are highly relevant as the leading cause of infant deaths around the world is identified as congenital heart defects. In the later stages of their life the patients will develop serious complications if these congenital defects are not treated or detectable at a young age.

Increasing use of patches are also a major driver for ePTFE and bovine repairs, for repairing hernias and soft tissues. Different types of hernias exist, such as hernias incisional, femoral, umbilical, paraumbilic, etc. Heavy lifting weight, abdominal intervention, chronic cough, constipation of as cites (fluid in the abdomen), and other conditions leading to increased pressure in the inner abdomen are key risk factors for hernia. Congenital diaphragmatic hernia is also one of the biggest causes of infant mortality. The rate of survival in the United States is nearly 50 percent for every 1 in 2,500 newborns and children diagnosed with CDH. In addition, the recurrence of a hernia following treatment is quite possible. The inguinal hernia has a recurrence rate of almost 2% and a recurrence rate of nearly 10-20%. These conditions are anticipated in the next seven years to substantially boost market growth.

Regional Snapshots

The overall revenue share of Asia Pacific dominated in 2014 by more than 59 percent. A large population basis prone to different cardiovascular and abdominal diseases that require surgical procedures is a key factor attributable to its large proportion. Furthermore, the constant improvement of health infrastructure and the high penetration of such patches are anticipated to boost market growth in economies like Japan, China, India and Australia.

Market Segmentation

Cardiovascular & Soft Tissue Repair Patches Market by Application

  • Vascular Repair & Reconstruction
  • Cardiac Repair
  • Pericardial Repair
  • Soft Tissue repair
  • Dural Repair

Cardiovascular & Soft Tissue Repair Patches Market by Raw Material

  • ePTFE
  • Biomaterial and Tissue Engineered Material
  • Others

Global Cardiovascular & Soft Tissue Repair Patches Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Cardiovascular & Soft Tissue Repair Patches Market (By Application: Vascular Repair & Reconstruction, Cardiac Repair, Pericardial Repair, Soft Tissue repair, Dural Repair; By Raw Material: ePTFE, Biomaterial and Tissue Engineered Material, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Cardiovascular & Soft Tissue Repair Patches market segments with market dynamics and their impact. The report provides insights on global Cardiovascular & Soft Tissue Repair Patches market by application, raw material and major geographic regions. The report also covers basic technology development policies.

Key Players

The Cardiovascular & Soft Tissue Repair Patches market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are CryoLife, Edwards Life Sciences ; Baxter ; Admedus ; Bard Peripheral Vascular, Inc ; Terumo Cardiovascular: W.L. Gore & Associates; and Others.

One of the crucial factors that indicate the current market competitiveness is the increasing number of fusions and acquisitions by certain key players, such as Terumo Cardiovascular and Medtronic.


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary